ResMed logo-fullcolor.jpg
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy
16 mai 2024 16h35 HE | ResMed Inc.
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy
ResMed logo-fullcolor.jpg
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
15 mars 2024 03h05 HE | ResMed Inc.
ResMed announced the results of its 2024 Global Sleep Survey, uncovering a world in sleep crisis and encouraging people to discover their sleep superpowers
ResMed logo-fullcolor.jpg
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask
06 mars 2024 09h05 HE | ResMed Inc.
ResMed unveils the AirFit F40, an ultra-compact full-face CPAP mask offering the comfort of smaller masks without sacrificing performance.
Blue California successfully completes groundbreaking human clinical trial of ergothioneine.
Blue California completes groundbreaking human clinical trial on ErgoActive® ergothioneine intervention for cognitive function, memory, and sleep
05 févr. 2024 04h00 HE | Blue California Ingredients
Rancho Santa Margarita, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Blue California, an industry leader in science-driven ingredient development, announced the successful completion of a...
Updatedprimary.png
Nox Health Closes Acquisition of Somryst, the Only FDA-Cleared Digital Insomnia Treatment, From Pear Therapeutics
20 juin 2023 11h56 HE | Nox Health
ALPHARETTA, Ga., June 20, 2023 (GLOBE NEWSWIRE) -- Nox Health, a global sleep health leader in sleep diagnostics and value-based sleep care management, today announced that it has closed the...
Nox Health & Somryst
Nox Health Acquires Somryst, the Only FDA-Cleared Digital Insomnia Treatment
25 mai 2023 09h46 HE | Nox Health
ALPHARETTA, Ga. , May 25, 2023 (GLOBE NEWSWIRE) --  Nox Health, a global sleep health leader, has acquired Somryst, the first FDA-cleared Prescription Digital Therapeutic (PDT) that delivers...
NoxT3s_NoxRIP2
UPDATE--Nox Medical Secures New Patent for Calculating Respiratory Effort During Sleep Studies
05 avr. 2023 16h31 HE | Nox Health
ALPHARETTA, Ga., April 05, 2023 (GLOBE NEWSWIRE) -- Nox Medical has secured a new patent to measure breathing movements for determining endophenotypes of sleep-disordered breathing using Nox RIP...
NoxT3s_NoxRIP2
Nox Medical Secures New Patent for Calculating Respiratory Effort During Sleep Studies
04 avr. 2023 15h53 HE | Nox Health
ALPHARETTA, Ga., April 04, 2023 (GLOBE NEWSWIRE) -- The United States Patent Office recently granted Nox Medical a new patent for methods supporting accurate diagnoses of sleep apnea, which are...
primary.png
Nox Health Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation
23 mars 2023 11h08 HE | Nox Health
ALPHARETTA, Ga., March 23, 2023 (GLOBE NEWSWIRE) -- Nox Health, a global sleep health leader, has joined the American Heart Association Center for Health Technology & Innovations (the Center)...
Hatch Restore 2
Hatch Announces Restore 2 to Help Adults Discover Moments of Rest and Build Healthy Sleep Habits
04 janv. 2023 09h02 HE | Hatch
PALO ALTO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Hatch, the company that’s helped millions of families sleep more soundly, introduced today a new version of its beloved sleep product for adults...